Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.

Abstract

BACKGROUND:

Estrogen receptors (ERs) are thought to play an important role in non-small cell lung cancer (NSCLC). However, the effect of ERs in NSCLC is still controversial and needs further investigation. A new consideration is that ERs may affect NSCLC progression through complicated molecular signaling networks rather than individual targets. Therefore, this study aims to explore the effect of ERs in NSCLC from the perspective of cancer systems biology.

METHODS:

The gene expression profile of NSCLC samples in TCGA dataset was analyzed by bioinformatics method. Variations of cell behaviors and protein expression were detected in vitro. The kinetic process of molecular signaling network was illustrated by a systemic computational model. At last, immunohistochemical (IHC) and survival analysis was applied to evaluate the clinical relevance and prognostic effect of key receptors in NSCLC.

RESULTS:

Bioinformatics analysis revealed that ERs might affect many cancer-related molecular events and pathways in NSCLC, particularly membrane receptor activation and signal transduction, which might ultimately lead to changes in cell behaviors. Experimental results confirmed that ERs could regulate cell behaviors including cell proliferation, apoptosis, invasion and migration; ERs also regulated the expression or activation of key members in membrane receptor signaling pathways such as epidermal growth factor receptor (EGFR), Notch1 and Glycogen synthase kinase-3β/β-Catenin (GSK3β/β-Catenin) pathways. Modeling results illustrated that the promotive effect of ERs in NSCLC was implemented by modulating the signaling network composed of EGFR, Notch1 and GSK3β/β-Catenin pathways; ERs maintained and enhanced the output of oncogenic signals by adding redundant and positive-feedback paths into the network. IHC results echoed that high expression of ERs, EGFR and Notch1 had a synergistic effect on poor prognosis of advanced NSCLC.

CONCLUSIONS:

This study indicated that ERs were likely to promote NSCLC progression by modulating the integrated membrane receptor signaling network composed of EGFR, Notch1 and GSK3β/β-Catenin pathways and then affecting tumor cell behaviors. It also complemented the molecular mechanisms underlying the progression of NSCLC and provided new opportunities for optimizing therapeutic scheme of NSCLC.

• Authors: Xiujuan Gao, Yue Cai, Zhuo Wang, Wenjuan He, Sisi Cao, Rong Xu, Hui Chen
• Journal: Journal of translational medicine (J Transl Med) Vol. 17 Issue 1 Pg. 308 (09 11 2019) ISSN: 1479-5876 [Electronic] England
• PMID: 31511014 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Receptor, Notch1
• Receptors, Estrogen
• beta Catenin
• ErbB Receptors
• Glycogen Synthase Kinase 3 beta

Topics

• Apoptosis (genetics)
• Carcinoma, Non-Small-Cell Lung (genetics, metabolism, pathology)
• Cell Line, Tumor
• Cell Movement (genetics)
• Cell Proliferation (genetics)
• Disease Progression
• ErbB Receptors (metabolism)
• Gene Expression Regulation, Neoplastic
• Gene Ontology
• Gene Regulatory Networks
• Glycogen Synthase Kinase 3 beta (metabolism)
• Humans
• Lung Neoplasms (genetics, metabolism, pathology)
• Neoplasm Invasiveness
• Prognosis
• Receptor, Notch1 (metabolism)
• Receptors, Estrogen (metabolism)
• Signal Transduction
• Systems Biology
• beta Catenin (metabolism)